Carfilnat 60mg Injection contains Carfilzomib, a proteasome inhibitor that is mostly used to treat multiple myeloma, a malignancy that affects bone marrow plasma cells.

Brand Name: Carfilnat

Composition: Carfilzomib

Mechanism of Action:

A major component in controlling protein degradation and preserving cellular homeostasis, the proteasome is selectively and irreversibly inhibited by carfilzomib. Its blockage causes damaged or misfolded proteins to accumulate, which stresses the cancer cells and eventually encourages cell death, especially in rapidly reproducing cells like multiple myeloma cells.

Uses:

Multiple Myeloma

Dosage and Administration:

The patient's health, responsiveness to treatment, and tolerability are taken into consideration while determining the dosage. The injection is usually given intravenously while being watched over by a medical practitioner.

Side Effects:

·                Anemia

·                Neutropenia

·                Thrombocytopenia

·                Fatigue

·                Nausea

·                Vomiting

·                Heart Failure

·                Numbness

·                Diarrhea

Safety Advise:

Lungs  

The safety of Carfilnat Injection for individuals with lung issues is uncertain. Kindly speak with your healthcare provider.

Liver  

The safety of Carfilnat Injection for individuals with liver issues is uncertain. Kindly speak with your healthcare provider.

Kidney  

The safety of Carfilnat Injection for individuals with Kidney issues is uncertain. Kindly speak with your healthcare provider.

Pregnancy  

Carfilnat should be used during pregnancy only if clearly needed, Kindly speak with your healthcare provider.

Breast Feeding  

Using Carfilnat while nursing is most likely dangerous. Kindly speak with your healthcare provider. 

Storage:

Carfilnat should be kept in the refrigerator between 2°C and 8°C (36°F and 46°F). The formulation may be harmed by freezing, so avoid doing so.

How to use this Medication?

Carfilzomib can be administered intravenously (into a vein) as a powder that is combined with a liquid. A physician or nurse administers carfilzomib in a clinic or doctor's office, typically over ten to thirty minutes. It can be taken twice a week for three weeks, followed by a 12-day break, or once a week for three weeks, followed by a 13-day break. How well your body reacts to the drug will determine how long your therapy will last.

Throughout your treatment, be sure to communicate your feelings to your doctor. If you have side effects from carfilzomib, your doctor may reduce your dosage or temporarily discontinue your therapy.

Disclaimer:

The main goal of Apothecare Wellness is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Wellness, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.